Market Size of Global DNA/RNA Extraction Kit Industry
| Study Period | 2019 - 2029 |
| Market Size (2024) | USD 1.64 Billion |
| Market Size (2029) | USD 2.33 Billion |
| CAGR (2024 - 2029) | 7.26 % |
| Fastest Growing Market | Asia-Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
DNA/RNA Extraction Kit Market Analysis
The Global DNA/RNA Extraction Kit Market size is estimated at USD 1.64 billion in 2024, and is expected to reach USD 2.33 billion by 2029, growing at a CAGR of 7.26% during the forecast period (2024-2029).
The COVID-19 pandemic impacted the DNA/RNA extraction kit market for the short time being due to restrictions on different business and research activities. Additionally, the diagnostics tests of other diseases and medical disorders in the hospitals and other clinical diagnostics establishments were affected due to a decrease in the turnout of the patients for tests because of COVID-19. However, the high infection rate of COVID-19 and research activities by key companies in the area of sequencing to expand their knowledge about the virus and its origin, along with molecular diagnostics of the SARS-CoV-2 virus, led to the development and launch of many DNA and RNA based COVID-19 kits, which proved to be very crucial and were in huge demand later. For instance, in April 2020, PHASE Scientific announced the commercial launch of the PHASIFY VIRAL RNA extraction kit for the detection of the COVID-19 virus, globally.
The major driving factor behind the growth of the DNA/RNA extraction kit market is the increasing investments in R&D activities in different fields, including molecular diagnostics for different chronic and infectious diseases. For example, according to the Organization for Economic Co-operation and Development, in 2018, the United States spent USD 552 billion on R&D activities, followed by China with USD 463 billion. The technological advancements, the launch of new products by the key market players, and rising cases of cancer, worldwide, may also complement the growth of the market studied. For instance, in June 2020, Omega Bio-tek Inc. announced the launch of an advanced viral RNA extraction kit for the COVID-19 testing, called Mag-Bind Viral RNA Xpress kit, for the efficient extraction of the Viral RNA from nasopharyngeal (NP) swab samples.
Other factors, such as increased demand in the automation of DNA/RNA extraction technology, new user-friendly and easy extraction kits, use of DNA/RNA in the profiling of new diseases causing microorganisms, are expected to boost the growth of the DNA/RNA extraction kit market during the forecast period. Thus, the low awareness and availability of the kits and less market penetration in the underdeveloped and developing regions, worldwide, are the major restraining factors for the growth of the DNA/RNA extraction kit market.
DNA/RNA Extraction Kit Industry Segmentation
The DNA/RNA extraction kits are used for isolating the DNA or RNA from any cell, which can be from any animal, microbe, or plant. The primary use of these extractions is for DNA or RNA profiling of various organisms to better understand and sometimes to identify the unknown organism. The global DNA/RNA extraction kit market is segmented by product (cell-free DNA, sequence-specific DNA, sequence-specific RNA, total RNA, and other products), application (hospitals, diagnostics centers, and research institutions), and geography (North America, Europe, Asia Pacific, Middle-East and Africa, and South America).
| By Product | |
| Cell Free DNA | |
| Sequence Specific DNA | |
| Sequence Specific RNA | |
| Total RNA | |
| Other Products |
| By End Users | |
| Hospitals | |
| Diagnostics Centers | |
| Research Institutions |
| By Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Global DNA/RNA Extraction Kit Market Size Summary
The DNA and RNA extraction kit market is poised for significant growth, driven by increasing investments in research and development across various fields, particularly molecular diagnostics for chronic and infectious diseases. The market experienced a temporary setback due to the COVID-19 pandemic, which disrupted business and research activities. However, the high infection rates and subsequent research efforts led to a surge in demand for DNA and RNA-based kits, particularly for COVID-19 testing. Technological advancements and the introduction of new products by key players, alongside the rising incidence of cancer globally, are expected to further propel market expansion. Despite these positive trends, challenges such as low awareness and limited market penetration in underdeveloped regions remain significant hurdles.
North America is a dominant region in the DNA and RNA extraction kit market, largely due to robust research and development activities and the presence of major market players. The United States, in particular, is expected to maintain a leading position, supported by substantial government and private sector investments in research, increasing demand for extraction kits, and a rising prevalence of chronic diseases like cancer. The competitive landscape of the market is characterized by the presence of both local and multinational companies, with major players such as Qiagen, Thermo Fisher Scientific, and Promega Corporation driving innovation and product development. New product launches and strategic expansions are anticipated to enhance market growth, with a focus on developing efficient and user-friendly kits to meet the evolving needs of researchers and healthcare professionals.
Global DNA/RNA Extraction Kit Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Increasing Investments in R&D of Molecular Diagnostics
-
1.2.2 Technological Advancements
-
1.2.3 Increasing Prevalence of Cancer Cases
-
-
1.3 Market Restraints
-
1.3.1 Lack of Awareness About the Kits
-
1.3.2 Low Market Penetration
-
-
1.4 Industry Attractiveness - Porter's Five Forces Analysis
-
1.4.1 Bargaining Power of Buyers/Consumers
-
1.4.2 Bargaining Power of Suppliers
-
1.4.3 Threat of New Entrants
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION
-
2.1 By Product
-
2.1.1 Cell Free DNA
-
2.1.2 Sequence Specific DNA
-
2.1.3 Sequence Specific RNA
-
2.1.4 Total RNA
-
2.1.5 Other Products
-
-
2.2 By End Users
-
2.2.1 Hospitals
-
2.2.2 Diagnostics Centers
-
2.2.3 Research Institutions
-
-
2.3 By Geography
-
2.3.1 North America
-
2.3.1.1 United States
-
2.3.1.2 Canada
-
2.3.1.3 Mexico
-
-
2.3.2 Europe
-
2.3.2.1 Germany
-
2.3.2.2 United Kingdom
-
2.3.2.3 France
-
2.3.2.4 Italy
-
2.3.2.5 Spain
-
2.3.2.6 Rest of Europe
-
-
2.3.3 Asia Pacific
-
2.3.3.1 China
-
2.3.3.2 Japan
-
2.3.3.3 India
-
2.3.3.4 Australia
-
2.3.3.5 South Korea
-
2.3.3.6 Rest of Asia Pacific
-
-
2.3.4 Middle-East and Africa
-
2.3.4.1 GCC
-
2.3.4.2 South Africa
-
2.3.4.3 Rest of Middle-East and Africa
-
-
2.3.5 South America
-
2.3.5.1 Brazil
-
2.3.5.2 Argentina
-
2.3.5.3 Rest of South America
-
-
-
Global DNA/RNA Extraction Kit Market Size FAQs
How big is the Global DNA/RNA Extraction Kit Market?
The Global DNA/RNA Extraction Kit Market size is expected to reach USD 1.64 billion in 2024 and grow at a CAGR of 7.26% to reach USD 2.33 billion by 2029.
What is the current Global DNA/RNA Extraction Kit Market size?
In 2024, the Global DNA/RNA Extraction Kit Market size is expected to reach USD 1.64 billion.
